Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
17.28 USD | +0.26% | +1.00% | -22.71% |
01:19pm | Earnings Flash (INMD) INMODE Posts Q1 EPS $0.32, vs. Street Est of $0.41 | MT |
01:02pm | InMode Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
Summary
- The company has strong fundamentals. More than 70% of companies have a lower mix of growth, profitability, debt and visibility.
- The company presents an interesting fundamental situation from a short-term investment perspective.
Strengths
- The company's EBITDA/Sales ratio is relatively high and results in high margins before depreciation, amortization and taxes.
- The group's activity appears highly profitable thanks to its outperforming net margins.
- Thanks to a sound financial situation, the firm has significant leeway for investment.
- The equity is one of the most attractive in the market with regard to earnings multiple-based valuation.
- The stock, which is currently worth 2024 to 0.91 times its sales, is clearly overvalued in comparison with peers.
- Given the positive cash flows generated by its business, the company's valuation level is an asset.
- The average target price set by analysts covering the stock is above current prices and offers a tremendous appreciation potential.
- Predictions on business development from analysts polled by Standard & Poor's are tight. This results from either a good visibility into core activities or accurate earnings releases.
- Historically, the company has been releasing figures that are above expectations.
Weaknesses
- The potential for earnings per share (EPS) growth in the coming years appears limited according to current analyst estimates.
- For the last twelve months, sales expectations have been significantly downgraded, which means that less important sales volumes are expected for the current fiscal year over the previous period.
- Revenue estimates are regularly revised downwards for the current and coming years.
- For the past year, analysts have significantly revised downwards their profit estimates.
- Over the past twelve months, analysts' opinions have been revised negatively.
Ratings chart - Surperformance
Sector: Advanced Medical Equipment & Technology
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
-22.71% | 1.46B | - | ||
+7.59% | 219B | B | ||
+5.42% | 183B | B- | ||
+10.37% | 132B | B- | ||
+23.42% | 106B | A- | ||
-2.66% | 62.09B | A- | ||
+4.81% | 50.88B | B+ | ||
+11.06% | 50.8B | B+ | ||
-0.90% | 40.64B | A | ||
+24.93% | 31.59B | B+ |
Financials
Valuation
Momentum
Consensus
Business Predictability
Technical analysis
- Stock Market
- Equities
- INMD Stock
- Ratings InMode Ltd.